Sanpras Healthcare Private Limited — Bromhexine Exporter Profile
Indian Pharmaceutical Exporter · #8 for Bromhexine · $359.7K export value · DGFT Verified
Sanpras Healthcare Private Limited is the #8 Indian exporter of Bromhexine with $359.7K in export value and 36 verified shipments. Sanpras Healthcare Private Limited holds a 2.2% market share in Bromhexine exports across 2 countries. The company exports 4 pharmaceutical products worth $2.3M across 3 therapeutic categories.
Sanpras Healthcare Private Limited — Bromhexine Export Profile: Buyers & Destinations
Where Does Sanpras Healthcare Private Limited Export Bromhexine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CHILE | $358.5K | 35 | 99.7% |
| NETHERLANDS ANTILLES | $1.2K | 1 | 0.3% |
Sanpras Healthcare Private Limited exports Bromhexine to 2 countries. The largest destination is CHILE accounting for 99.7% of Sanpras Healthcare Private Limited's Bromhexine shipments. These destinations reflect Sanpras Healthcare Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bromhexine from Sanpras Healthcare Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| OPKO CHILE S.A., | CHILE | $261.7K | 18 |
| OPKO CHILE S,A, | CHILE | $74.5K | 15 |
| OPKO CHILE S A | CHILE | $22.3K | 2 |
| BETTER PHARMA | NETHERLANDS ANTILLES | $1.2K | 1 |
Sanpras Healthcare Private Limited supplies Bromhexine to 4 buyers globally. The largest buyer is OPKO CHILE S.A., (CHILE), followed by OPKO CHILE S,A, (CHILE) and OPKO CHILE S A (CHILE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Bromhexine Export Value and How Much Does Sanpras Healthcare Private Limited Contribute?
India exported $10.3M worth of Bromhexine through 1,945 shipments from 288 suppliers to 109 countries, serving 530 buyers globally. Sanpras Healthcare Private Limited contributes $359.7K to this total, accounting for 2.2% of India's Bromhexine exports. Sanpras Healthcare Private Limited ships Bromhexine to 2 countries through 4 buyers.
What Is the Average Shipment Value for Sanpras Healthcare Private Limited's Bromhexine Exports?
Sanpras Healthcare Private Limited's average Bromhexine shipment value is $10.0K per consignment, based on 36 shipments totaling $359.7K. The largest destination is CHILE (99.7% of Sanpras Healthcare Private Limited's Bromhexine exports).
How Does Sanpras Healthcare Private Limited Compare to Other Indian Bromhexine Exporters?
Sanpras Healthcare Private Limited ranks #8 among 288 Indian Bromhexine exporters with a 2.2% market share. The top 3 exporters are UMAVIDA PHARMA PRIVATE LIMITED ($2.6M), EMCURE PHARMACEUTICALS LIMITED ($2.1M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($907.7K). Sanpras Healthcare Private Limited processed 36 shipments to 2 destination countries.
What Bromhexine Formulations Does Sanpras Healthcare Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| BROMHEXINE SYRUP 4MG/5ML (BROMHEXINA JBE | $112.2K | 7 |
| BROMHEXINE SYRUP 4MG/5ML (BROMHXINA JBE. | $68.0K | 6 |
| BROMHEXINE SYRUP 4MG/5ML (BROMHEXINE JBE. 4MG/5ML X 100ML MFG DATE:MAR-2025 EXP DATE:FEB-2027 BATCH NO: SH852 | $36.9K | 2 |
| BROMHEXINE HCL SYRUP 4MG/5ML ( BROMHEXINA JBE .HCL4MG/5,MLX100 L) BATCH NO SH852401 ( QTY 48960 ) | $31.6K | 6 |
| BROMHEXINE SYRUP 4MG/5ML(BROMHEXINA JBE. | $22.4K | 1 |
| BROMHEXINE HCL SYRUP 4MG/5ML BROMHEXINA | $22.3K | 2 |
| BROMHEXINE HCL SYRUP 4MG/5ML (BROMHEXINA | $22.2K | 2 |
| BROMHEXINE HCL SYRUP 4MG/5ML ( BROMHEXINA JBE .HCL4MG/5,MLX100 L) BATCH NO SH852402 ( QTY 49020) | $18.6K | 3 |
| BROMHEXINE HCL SYRUP 4MG/5ML ( BROMHEXINA JBE .HCL4MG/5,MLX100 L) BATCH NO SH852404 ( QTY 49020) | $18.6K | 3 |
| BROMHEXINE HCL SYRUP 4MG/5ML ( BROMHEXINA JBE .HCL4MG/5,MLX100 L) BATCH NO SH852403 ( QTY 15000 | $5.7K | 3 |
Sanpras Healthcare Private Limited exports 11 distinct Bromhexine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is BROMHEXINE SYRUP 4MG/5ML (BROMHEXINA JBE with 7 shipments worth $112.2K.
How Does Sanpras Healthcare Private Limited Compare to Nearest Bromhexine Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | LINCOLN PHARMACEUTICALS LTD | $600.0K | 12 | 5 | $50.0K |
| 7 | GLENMARK PHARMACEUTICALS LIMITED | $595.1K | 31 | 7 | $19.2K |
| 8 | SANPRAS HEALTHCARE PRIVATE LIMITED ★ | $359.7K | 36 | 2 | $10.0K |
| 9 | MEDREICH LIMITED | $337.7K | 88 | 2 | $3.8K |
| 10 | IPCA LABORATORIES LIMITED | $308.0K | 20 | 3 | $15.4K |
Sanpras Healthcare Private Limited ranks #8 among 288 Indian Bromhexine exporters. Average shipment value of $10.0K compared to the market average of $35.7K. The closest competitors by value are LINCOLN PHARMACEUTICALS LTD and GLENMARK PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Bromhexine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 303 | 15.6% |
| JNPT | 169 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 164 | 8.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 157 | 8.1% |
| AHEMDABAD ICD | 74 | 3.8% |
| SAHAR AIR | 73 | 3.8% |
| AHEMDABAD AIR ACC (INAMD4) | 72 | 3.7% |
| AHEMDABAD ICD (INSBI6) | 59 | 3.0% |
What Other Respiratory & OTC Products Does Sanpras Healthcare Private Limited Export?
Sanpras Healthcare Private Limited also exports these respiratory & otc products. Each links to the detailed product page.
About Sanpras Healthcare Private Limited
Sanpras Healthcare Private Limited exports 4 products worth $2.3M. Beyond Bromhexine, top products include Lactulose, Ambroxol, Melatonin. View the complete Sanpras Healthcare Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bromhexine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bromhexine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Sanpras Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 36 individual customs records matching Sanpras Healthcare Private Limited exporting Bromhexine, covering 11 formulations to 2 countries via 4 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 530+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bromhexine Export Data from Sanpras Healthcare Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Sanpras Healthcare Private Limited's Bromhexine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Sanpras Healthcare Private Limited
Full Company Profile →
4 products · $2.3M total trade · 3 categories
Bromhexine Stats
Company Overview
Top Products by Sanpras Healthcare Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Sanpras Healthcare Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bromhexine. For current shipment-level data, contact TransData Nexus.